肺动脉静脉形形:并非所有COVID-19期间的低氧症都是一样的
Ramitha Ramachandran1, Anuroop Balagopal1, Nilanjan Umesh1
1Department of Critical Care Medicine, Aster Medcity, Kochi, India.
European journal of case reports in internal medicine
|December 9, 2024
概括
在COVID-19患者中,持续性低氧化症可能源于血管分流,如肺动脉静脉形,而不仅仅是肺损伤. 一份病例报告强调了一名患者,由于这种组合,他的病情恶化.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 在COVID-19中缺氧症通常归因于气泡膜损伤.
- 血管短路,包括肺动脉静脉形形 (PAVMs),也可能导致低氧化.
- COVID-19 感染可能会加剧已经存在的 PAVMs.
研究的目的:
- 为了呈现一个COVID-19肺炎病例与并发的肺动脉静脉囊 (PAVF).
- 为了探索PAVF对COVID-19患者持续性低氧症的贡献.
主要方法:
- 一个59岁的男性患有COVID-19肺炎的病例报告.
- 使用高流量呼吸辅助器.
- 大型肺动脉静脉囊的诊断得到确认.
主要成果:
- 尽管接受了COVID-19治疗,但患者患有持续的低氧化血.
- 大型肺动脉静脉囊被确定为导致因素.
- COVID-19 感染可能使 PAVF 恶化.
结论:
- 在COVID-19中缺氧是多因素的,涉及膜损伤和诸如PAVM之类的血管短路.
- 由于症状与其他呼吸道疾病重叠,诊断PAVM可能具有挑战性.
- PAVM的管理通常涉及过导管栓塞,手术只适用于严重病例.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
172
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
172
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Pulmonary Hypertension: Classification and Pathogenesis
150
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
150
Pneumothorax-I
169
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
169
COPD: Pathogenesis and Clinical Features
232
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
232
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


